Home > Healthcare > Medical Devices > Medical Supplies > tourniquet systems market
Get a free sample of Tourniquet Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Tourniquet Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Increasing prevalence of degenerative bone disorders and musculoskeletal diseases among adult population is expected to boost the market size. Degenerative bone disorders and musculoskeletal diseases often require surgical interventions for treatment. These may include fracture repairs, orthopaedic surgeries to address complications from these conditions.
For instance, according to the CDC, in the U.S., currently there are more than 2.6 million people that are affected by osteoporosis escalating the demand for orthopedic surgeries. Tourniquet systems are commonly used during these surgeries to achieve bloodless surgical fields, improve visibility for surgeons, and reduce blood loss. Therefore, increasing prevalence of degenerative bone disorders and musculoskeletal diseases, along with the aforementioned factors, are expected to contribute to a growing demand for tourniquet systems in surgical and orthopedic settings.
Global market for tourniquet systems was valued at USD 437 million in 2022 and will exceed USD 941 million by 2032 owing to the increasing prevalence of degenerative bone disorders and musculoskeletal diseases among the adult population.
The tourniquet cuffs market accounted for more than 68% of the total market share in 2022 as a result of various advantages including the capability to control haemorrhage and minimize blood loss and improved visualization and controlled bleeding.
The U.S. tourniquet systems market is slated to reach around USD 358 million by 2032 on account of an increase in the number of chronic diseases, and rising awareness regarding the benefits of tourniquet systems for diagnosis and treatment of joint ailments among others in the country.
The lower-limb segment is anticipated to grow at 7.6% CAGR from 2023 to 2032, driven by its enhanced surgical precision, reduced blood loss, and improved post-operative pain control in the procedure.